Registration 333-284183
S-1/A · 2025-01-10 · 0001753926-25-000076
Terms from the governing filing for this registration; not a claim that the offering is open today.
Company research
Aspargo Labs, Inc.
CIK 1805092Updated Sep 25, 2026
Name history
Aspargo Laboratories, Inc. · through Sep 13, 2024
Filing activity
Latest filing
11 filings on record · RW, S-1/A, S-1, DRS/A, DRS, D.
About the company
Aspargo is a commercial stage specialty pharmaceutical and med-tech company focused on designing, developing and marketing proprietary, oral liquid suspension formulations of leading oral solid dose prescription (Rx) and over-the-counter (OTC) medications dispensed through “smart”, digitally connected, container closure drug delivery systems and associated mobile apps.
Recent filings
Show 5 more recent filings
Offerings
Registration 333-284183
Filing attachments
g084632_ex107.htm · S-1 · 2025-01-10
EX-FILING FEES 26 g084632_ex107.htm EXHIBIT 107 Exhibit 107 CALCULATION OF FILING FEE TABLE FORM S-1 (Form type) Aspargo Labs, Inc. (Exact name of Registrant as specified in its charter) Table 1: Newly Registered Securities Security Security Fee Amount Proposed Ma…
Read attachment ↗